Valneva SE
2.9270
02-May-25 11:22:48
15 minutes delayed
Stocks
+0.0430
+1.49%
Today's range
2.8840 - 2.9780
ISIN
FR0004056851
Source
Cboe
-
Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration
16 Sep 2022 16:30:00 By Nasdaq GlobeNewswire
-
Valneva and VBI Vaccines Announce European Partnership for Marketing and Distribution of PreHevbri®
08 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases
06 Sep 2022 01:00:00 By Nasdaq GlobeNewswire
-
VALNEVA - Declaration of shares and voting rights: August 31, 2022
05 Sep 2022 12:00:00 By Nasdaq GlobeNewswire
-
29 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
Valneva Confirms WHO Recommendations for its Inactivated COVID-19 Vaccine
23 Aug 2022 11:45:00 By Nasdaq GlobeNewswire
-
18 Aug 2022 12:00:00 By Nasdaq GlobeNewswire
-
Valneva Provides Update on IXIARO® Supply Contract with U.S. Department of Defense
18 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
Valneva Establishes an At-the-Market (ATM) Program on Nasdaq
15 Aug 2022 01:00:00 By Nasdaq GlobeNewswire
-
Valneva Reports H1 2022 Results and Provides Corporate Updates
11 Aug 2022 01:00:00 By Nasdaq GlobeNewswire